Acusphere Inc ACUS:OTCPK

RT Quote | Exchange | USD
Last | 2:17 PM EST
0.029quote price arrow down-0.02 (-40.8163%)
Volume
2,500
52 week range
0.01 - 0.18

...

Loading . . .

KEY STATS

  • Open0.038
  • Day High0.038
  • Day Low0.029
  • Prev Close0.049
  • 52 Week High0.18
  • 52 Week High Date03/20/20
  • 52 Week Low0.01
  • 52 Week Low Date09/14/20
  • Market Cap140,000.00
  • Shares Out4.95M
  • 10 Day Average Volume0.00M
  • Dividend-
  • Dividend Yield-
  • Beta-0.33
  • 1 Year % Change-43.14

RATIOS/PROFITABILITY

  • EPS (TTM)-14.48
  • P/E (TTM)-0.00
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-32.427M
  • ROE (MRQ)-
  • Revenue (MRQ)2.68M
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-2,523.62%
  • Debt To Equity (MRQ)-92.66%

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest Acusphere Inc News

There is no recent news for this security.

Latest ACUS News From Our Partners

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
Acusphere, Inc. is a specialty pharmaceutical company. The Company is focused on the development of Imagify, which contains Perflubutane Polymer Microspheres for injectable suspension. The Company's product Imagify is a cardiovascular drug for the detection of coronary artery disease (CAD). Imagify injectable suspension consists of porous, synthetic polymer microspheres containing gas that are administered intravenously and act as tracers of blood flow or perfusion. The...
Martyn Greenacre
Chairman
Sherri Oberg
Vice Chairman
Mark Leuchtenberger
President
Address
99 Hayden Ave Ste 385
Lexington, MA
02421-7998
United States